Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Translational regulation of the human cytomegalovirus pp28 (UL99) late gene

View through CrossRef
The pp28 (UL99) gene of human cytomegalovirus is expressed as a true late gene, in that DNA synthesis is absolutely required for mRNA expression. Our previous studies demonstrated that pp28 promoter sequences from position -40 to +106 are sufficient for late gene expression in the context of the viral genome (C. P. Kohler, J. A. Kerry, M. Carter, V. P. Muzithras, T. R. Jones, and R. M. Stenberg, J. Virol. 68:6589-6597, 1994). To extend these studies, we have examined the sequences in the downstream leader region of the pp28 gene for their role in late gene expression. Deletion of sequences from position -6 to +46 (deltaSS) results in a threefold increase in gene expression in transient assays. In contrast, deletion of sequences from position +46 to +88 (deltaA) has little effect on gene expression. These results indicate that the sequences from position -6 to +46 may repress gene expression. To further analyze this region, site-directed mutagenesis was performed. Mutation of residues from either position +1 to +6 (SS1) or position +12 to +17 (SS2) duplicated the effect of the deltaSS deletion mutant, indicating that sequences from position +1 to +17 were important for the inhibitory effect. To assess the biological significance of these events, a recombinant virus construct containing the deltaSS mutant promoter regulating expression of the chloramphenicol acetyltransferase (CAT) reporter gene was generated. Analysis of this virus (RV delta SSCAT) revealed that deletion of sequences from position -6 to +46 does not alter the kinetic class of this promoter. However, the ratio of CAT protein to CAT mRNA levels in RV delta SSCAT-infected cells was 8- to 12-fold higher than that observed in the parental RV24/26CAT-infected cells. These results imply that the leader sequences within the pp28 gene can regulate the translation of this late gene.
Title: Translational regulation of the human cytomegalovirus pp28 (UL99) late gene
Description:
The pp28 (UL99) gene of human cytomegalovirus is expressed as a true late gene, in that DNA synthesis is absolutely required for mRNA expression.
Our previous studies demonstrated that pp28 promoter sequences from position -40 to +106 are sufficient for late gene expression in the context of the viral genome (C.
P.
Kohler, J.
A.
Kerry, M.
Carter, V.
P.
Muzithras, T.
R.
Jones, and R.
M.
Stenberg, J.
Virol.
68:6589-6597, 1994).
To extend these studies, we have examined the sequences in the downstream leader region of the pp28 gene for their role in late gene expression.
Deletion of sequences from position -6 to +46 (deltaSS) results in a threefold increase in gene expression in transient assays.
In contrast, deletion of sequences from position +46 to +88 (deltaA) has little effect on gene expression.
These results indicate that the sequences from position -6 to +46 may repress gene expression.
To further analyze this region, site-directed mutagenesis was performed.
Mutation of residues from either position +1 to +6 (SS1) or position +12 to +17 (SS2) duplicated the effect of the deltaSS deletion mutant, indicating that sequences from position +1 to +17 were important for the inhibitory effect.
To assess the biological significance of these events, a recombinant virus construct containing the deltaSS mutant promoter regulating expression of the chloramphenicol acetyltransferase (CAT) reporter gene was generated.
Analysis of this virus (RV delta SSCAT) revealed that deletion of sequences from position -6 to +46 does not alter the kinetic class of this promoter.
However, the ratio of CAT protein to CAT mRNA levels in RV delta SSCAT-infected cells was 8- to 12-fold higher than that observed in the parental RV24/26CAT-infected cells.
These results imply that the leader sequences within the pp28 gene can regulate the translation of this late gene.

Related Results

CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN WITH HIV INFECTION
CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN WITH HIV INFECTION
Purpose: еstablishment of the frequency of infection and clinical forms of cytomegalovirus infection in pregnant women with HIV infection. Materials and methods. A retrospective an...
Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients
Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients
Background Currently, there are no prospective, randomized trials analyzing leflunomide for the treatment of cytomegalovirus infection or disease in allogeneic stem cell transplant...
Expression and polymorphism of genes in gallstones
Expression and polymorphism of genes in gallstones
ABSTRACT Through the method of clinical case control study, to explore the expression and genetic polymorphism of KLF14 gene (rs4731702 and rs972283) and SR-B1 gene...
Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
Congenital cytomegalovirus infection is a major cause of central nervous system and sensory impairments that affect cognition, motor function, hearing, language development, vestib...
Cyclophilin A as a target in the treatment of cytomegalovirus infections
Cyclophilin A as a target in the treatment of cytomegalovirus infections
Background Viruses are obligate parasites that depend on the cellular machinery of the host to regenerate and manufacture their proteins. Most antiviral drugs on the market today t...
2018
2018
OBJECTIVES/SPECIFIC AIMS: Translating conventional and regenerative medicine strategies from the research laboratory into the clinic is a complex process that can delay bringing no...
Translational Research in Audiology: Presence in the Literature
Translational Research in Audiology: Presence in the Literature
Translational research is a process that focuses on advancing basic research-based clinical solutions and is characterized by a structured process accelerating the implementation o...

Back to Top